1-6 of 6
Carmino A. de Souza, MD
Close
Sort by
Journal Articles

Evaluation of Peroxiredoxins (PRDX1, PRDX2 and PRDX6) Expression in Patients with Chronic Myeloid Leukemia (CML) Treated with Imatinib in First Line

Cintia Mascarenhas, Lara Woldmar, Maria Helena Almeida, PhD, Rosangela Vieira Andrade, PhD, Anderson Ferreira Cunha, Carmino A De Souza, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5545.
https://doi.org/10.1182/blood.V124.21.5545.5545
Published: 2014
Journal Articles

Brazilian Experience Using High Dose Sequential (HDS) Followed by Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Relapse/Refractory Aggressive Non-Hodgkin Lymphoma (NHL).

Bruno K.L. Duarte, MD, I.S. Valente, MD, Afonso C. Vigorito, MD, Francisco J.P. Aranha, MD, Gislaine B. Oliveria, MD, Eliana C.M. Miranda, Irene Lorand-Metze, PhD, Katia B.B. Pagnano, MD, Carmino A. De Souza, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 5102.
https://doi.org/10.1182/blood.V110.11.5102.5102
Published: 2007
Journal Articles

High Dose Sequential (HDS) Followed by Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Salvage Treatment of Hodgkin’s Disease (HD): A Brazilian Experience.

Bruno K.L. Duarte, MD, I.S. Valente, MD, Afonso C. Vigorito, MD, Francisco J.P. Aranha, MD, Gislaine B. Oliveira, MD, Eliana C.M. Miranda, Irene Lorand-Metze, PhD, Katia B.B. Pagnano, MD, Carmino A. De Souza, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 5103.
https://doi.org/10.1182/blood.V110.11.5103.5103
Published: 2007
Journal Articles

Detection of BCR-ABL Point Mutations in Patients with Chronic Myeloid Leukemia (CML) Resistant to Imatinib.

Rosana A. Silveira, Dulcineia M. Albuquerque, PhD, Angela M. Assis, Edson Ichihara, Carmino A. de Souza, MD,PhD, Fernando F. Costa, MD,PhD, Marcia T. Delamain, MD, Afonso C. Vigorito, MD,PhD, Irene Lorand-Metze, MD,PhD, Eliana Miranda, Katia B.B. Pagnano, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 4817.
https://doi.org/10.1182/blood.V108.11.4817.4817
Published: 2006
Journal Articles

High-Dose Sequential Chemotherapy Versus a Less Intensive Chemotherapeutic Regimen Followed by Peripheral Blood Progenitor Cell Autografting in Patients with Advanced Hodgkin’s Disease.

Marcio Nucci, MD, Katia Urago, MD, Eliana A. Miranda, Marcia Delamain, MD, Joao T. Souto Filho, MD, Silvia F. Matte, MD, Carla M. Duarte, MD, Gislaine B. Oliveira, MD, Afonso C. Vigorito, MD, Katia B. Pagnano, MD, Angelo Maiolino, MD, Carmino A. de Souza, MD
Journal: Blood
Blood (2005) 106 (11): 5485.
https://doi.org/10.1182/blood.V106.11.5485.5485
Published: 2005
Journal Articles

High Frequency of Point Mutations of BCR/ABL Gene in CML Patients Resistant to Imatinib Therapy - Report of a Novel Mutation.

Edson Ichihara, Fernando F. Costa, MD, Natasha Busoli, Dulcineia M. Albuquerque, Irene Lorand-Metze, MD, Sara T.O. Saad, MD, Carmino A. De Souza, MD, Afonso C. Vigorito, MD, Katia B.B. Pagnano, MD
Journal: Blood
Blood (2004) 104 (11): 4661.
https://doi.org/10.1182/blood.V104.11.4661.4661
Published: 2004